Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque and Dyslipidemia
NCT07314775Phase 4Not yet recruiting
- Sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
- Start
- Jan 2026
- Primary completion
- Jul 2028
01
Overview
Phase 4, randomised, double-blind trial in carotid atherosclerotic plaque (CAS) and dyslipidemia, sponsored by Xinjiang Uygur Pharmaceutical Co., Ltd. Primary endpoint: carotid intima-media thickness at 12 months. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
carotid atherosclerotic plaque (CAS)dyslipidemia
Beyond the preview
Go deeper on NCT07314775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07314775.